PharmGKB summary: very important pharmacogene information for CYP4F2

被引：31
作者：
Alvarellos, Maria L. [1 ]
Sangkuhl, Katrin [1 ]
Daneshjou, Roxana [1 ]
Whirl-Carrillo, Michelle [1 ]
Altman, Russ B. [1 ,2 ]
Klein, Teri E. [1 ]
机构：
[1] Stanford Univ, Dept Genet, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA
来源：
PHARMACOGENETICS AND GENOMICS | 2015年 / 25卷 / 01期
关键词：
arachidonic acid; eicosanoids; menaquinone; 4; pharmacogenomics; phylloquinone; -tocopherol; vitamin E; vitamin K; warfarin; B-4; OMEGA-HYDROXYLASE; WARFARIN DOSE REQUIREMENTS; VITAMIN-E; LEUKOTRIENE B-4; BLOOD-PRESSURE; HUMAN LIVER; 20-HYDROXYEICOSATETRAENOIC ACID; NONALCOHOLIC STEATOHEPATITIS; GENETIC-VARIANTS; COMMON VARIANTS;
D O I：
10.1097/FPC.0000000000000100
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：41 / 47
页数：7
相关论文
共 63 条
[1]   Oral anticoagulant drug interactions with statins: Case report of fluvastatin and review of the literature [J].
Andrus, MR .
PHARMACOTHERAPY, 2004, 24 (02) :285-290
[2]   Genetic Polymorphism of Cytochrome P450 4F2, Vitamin E Level and Histological Response in Adults and Children with Nonalcoholic Fatty Liver Disease Who Participated in PIVENS and TONIC Clinical Trials [J].
Athinarayanan, Shaminie ;
Wei, Rongrong ;
Zhang, Min ;
Bai, Shaochun ;
Traber, Maret G. ;
Yates, Katherine ;
Cummings, Oscar W. ;
Molleston, Jean ;
Liu, Wanqing ;
Chalasani, Naga .
PLOS ONE, 2014, 9 (04)
[3]   Common Variants of Cytochrome P450 4F2 Exhibit Altered Vitamin E-ω-Hydroxylase Specific Activity [J].
Bardowel, Sabrina A. ;
Stec, David E. ;
Parker, Robert S. .
JOURNAL OF NUTRITION, 2010, 140 (11) :1901-1906
[4]   Effects of CYP4F2 Polymorphism on Response to Warfarin During Induction Phase: A Prospective, Open-Label, Observational Cohort Study [J].
Bejarano-Achache, Idit ;
Levy, Liran ;
Mlynarsky, Liat ;
Bialer, Meir ;
Muszkat, Mordechai ;
Caraco, Yoseph .
CLINICAL THERAPEUTICS, 2012, 34 (04) :811-823
[5]   PREVALENCE OF HYPERTENSION IN THE US ADULT-POPULATION - RESULTS FROM THE 3RD NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEY, 1988-1991 [J].
BURT, VL ;
WHELTON, P ;
ROCCELLA, EJ ;
BROWN, C ;
CUTLER, JA ;
HIGGINS, M ;
HORAN, MJ ;
LABARTHE, D .
HYPERTENSION, 1995, 25 (03) :305-313
[6]   CYP4F2 genetic variant alters required warfarin dose [J].
Caldwell, Michael D. ;
Awad, Tarif ;
Johnson, Julie A. ;
Gage, Brian F. ;
Falkowski, Mat ;
Gardina, Paul ;
Hubbard, Jason ;
Turpaz, Yaron ;
Langaee, Taimour Y. ;
Eby, Charles ;
King, Cristi R. ;
Brower, Amy ;
Schmelzer, John R. ;
Glurich, Ingrid ;
Vidaillet, Humberto J. ;
Yale, Steven H. ;
Zhang, Kai Qi ;
Berg, Richard L. ;
Burmester, James K. .
BLOOD, 2008, 111 (08) :4106-4112
[7]   Genetic and Clinical Predictors of Warfarin Dose Requirements in African Americans [J].
Cavallari, L. H. ;
Langaee, T. Y. ;
Momary, K. M. ;
Shapiro, N. L. ;
Nutescu, E. A. ;
Coty, W. A. ;
Viana, M. A. G. ;
Patel, S. R. ;
Johnson, J. A. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (04) :459-464
[8]   CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement [J].
Cen, Han-Jing ;
Zeng, Wu-Tao ;
Leng, Xiu-Yu ;
Huang, Min ;
Chen, Xiao ;
Li, Jia-Li ;
Huang, Zhi-Ying ;
Bi, Hui-Chang ;
Wang, Xue-Ding ;
He, Yan-Ling ;
He, Fan ;
Zhou, Rui-Na ;
Zheng, Qi-Shan ;
Zhao, Li-Zi .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (02) :234-240
[9]   Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design [J].
Chalasani, Naga P. ;
Sanyal, Arun J. ;
Kowdley, Kris V. ;
Robuck, Patricia R. ;
Hoofnagle, Jay ;
Kleiner, David E. ;
Uenalp, Aynur ;
Tonascia, James .
CONTEMPORARY CLINICAL TRIALS, 2009, 30 (01) :88-96
[10]   Menopause and hypertension - An age-old debate [J].
Coylewright, Megan ;
Reckelhoff, Jane F. ;
Ouyang, Pamela .
HYPERTENSION, 2008, 51 (04) :952-959
1234567